Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

Robert Stuver 1, Gunjan L Shah 2, Neha S Korde 3, Lindsey E Roeker 4, Anthony R Mato 4, Connie L Batlevi 1, David J Chung 2, Sital Doddi 5, Lorenzo Falchi 1, Boglarka Gyurkocza 2, Audrey Hamilton 1, Ya-Hui Lin, Ann A Jakubowski, Erel Joffe, Heather L Landau, Richard J Lin, Sham Mailankody, M Lia Palomba, Jae H Park, Miguel-Angel Perales, Doris M Ponce, Lakshmi V Ramanathan, Gilles A Salles, Michael Scordo, Susan K Seo, Urvi A Shah, Eytan M Stein, David Straus, Saad Z Usmani, James W Young, Andrew D Zelenetz, Ariela Noy, Santosha A Vardhana

Cancer Cell. 2022 Jun 13;40(6):590-591.